IL4I1 and glioblastoma: Collectively, this study emphasises the crucial roles of IL4I1 in anti‐ferroptosis through Nrf2 signalling pathway but not AHR pathway by catabolism tryptophan, suggesting IL4I1 and tryptophan reprogramming as potential therapeutic targets for GBM.